Teleflex Incorporated (TFX)

NYSE: TFX · IEX Real-Time Price · USD
286.34
-6.42 (-2.19%)
May 18, 2022 4:05 PM EDT - Market closed
Market Cap13.43B
Revenue (ttm)2.82B
Net Income (ttm)487.65M
Shares Out46.90M
EPS (ttm)10.28
PE Ratio27.85
Forward PE20.12
Dividend$1.36 (0.47%)
Ex-Dividend DateMay 13, 2022
Volume605,988
Open290.19
Previous Close292.76
Day's Range285.52 - 291.47
52-Week Range256.77 - 428.36
Beta1.05
AnalystsBuy
Price Target366.28 (+27.9%)
Earnings DateApr 28, 2022

About TFX

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional prod...

IndustryHealth Care Equipment & Supplies
Founded1943
CEOLiam Kelly
Employees14,000
Stock ExchangeNYSE
Ticker SymbolTFX
Full Company Profile

Financial Performance

In 2021, Teleflex's revenue was $2.81 billion, an increase of 10.74% compared to the previous year's $2.54 billion. Earnings were $485.37 million, an increase of 44.75%.

Financial Statements

Analyst Forecast

According to 15 analysts, the average rating for TFX stock is "Buy." The 12-month stock price forecast is 366.28, which is an increase of 27.92% from the latest price.

Price Target
$366.28
(27.92% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Teleflex Announces Regulatory Clearance for its UroLift® System in China for the Treatment of Benign Prostatic Hyperp...

Will expand patient access to BPH treatment Will expand patient access to BPH treatment

2 hours ago - GlobeNewsWire

Teleflex Announces Health Canada Approval of MANTA® Vascular Closure Device

WAYNE, Pa., May 18, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today has announced that it received Health Canada approval for the MAN...

1 day ago - GlobeNewsWire

Teleflex Announces Full U.S. Commercial Launch of the UroLift® 2 System and UroLift ATC ® Advanced Tissue Control System

Product demonstrations and educational presentations underscore the company's leadership in advancing care for patients with benign prostatic hyperplasia (BPH) Product demonstrations and educational pre...

6 days ago - GlobeNewsWire

Teleflex to Host Analyst & Investor Day on May 20, 2022

WAYNE, Pa., May 02, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced that the Company will host an Analyst & Investor Day on Friday, May 20, 2022 in New York Ci...

2 weeks ago - GlobeNewsWire

Teleflex Announces Quarterly Dividend

WAYNE, Pa., May 02, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of co...

2 weeks ago - GlobeNewsWire

Teleflex's (TFX) Q1 Earnings Top Estimates, Margins Down

Teleflex (TFX) exhibits year-over-year growth across the Americas, EMEA and Asia regions at CER in the first quarter.

2 weeks ago - Zacks Investment Research

Teleflex (TFX) Tops Q1 Earnings and Revenue Estimates

Teleflex (TFX) delivered earnings and revenue surprises of 5.49% and 1.58%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

2 weeks ago - Zacks Investment Research

Teleflex Reports First Quarter Financial Results And Full Year Outlook

WAYNE, Pa., April 28, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the first quarter ended March 27, 2022.

3 weeks ago - GlobeNewsWire

Teleflex Named to Forbes Best Employers for Diversity 2022 List

WAYNE, Pa., April 26, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it has been named to the Forbes Best Employers for Di...

3 weeks ago - GlobeNewsWire

Teleflex to Present at the Bank of America Securities 2022 Healthcare Conference

WAYNE, Pa., April 26, 2022 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Bank of America Securities 2022 Healthcare Confere...

3 weeks ago - GlobeNewsWire

Teleflex (TFX) Expected to Beat Earnings Estimates: Should You Buy?

Teleflex (TFX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 weeks ago - Zacks Investment Research

Teleflex Announces First Quarter 2022 Earnings Conference Call Information

WAYNE, Pa., April 14, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its first quarter 2022 results, and provide an operational update at 8:00 a.m. East...

1 month ago - GlobeNewsWire

Teleflex Announces the Launch of the UroLift® System in Japan for the Treatment of Benign Prostatic Hyperplasia (BPH)

Initial Cases Have Now Been Performed in Japan Initial Cases Have Now Been Performed in Japan

1 month ago - GlobeNewsWire

Here's Why You Should Retain Teleflex (TFX) Stock for Now

Investors are optimistic about Teleflex (TFX) on increased UroLift demand and strong vascular business.

1 month ago - Zacks Investment Research

Teleflex (TFX) Hurt by Urolift Cancellations, Cost Woes

Teleflex (TFX) continues to face supply-chain challenges and freight logistic delays.

2 months ago - Zacks Investment Research

Teleflex to Present at the KeyBanc Life Sciences & MedTech Investor Forum

WAYNE, Pa., March 09, 2022 (GLOBE NEWSWIRE) -- Thomas Powell, Executive Vice President and Chief Financial Officer, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the KeyBanc Life Sciences ...

2 months ago - GlobeNewsWire

Teleflex to Present at the 43rd Annual Raymond James Institutional Investors Conference

WAYNE, Pa., March 02, 2022 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 43rd Annual Raymond James Institutional Investors ...

2 months ago - GlobeNewsWire

Teleflex (TFX) Q4 Earnings & Revenues Top Estimates, Margins Up

Strong segmental performance in the domestic and international markets is driving Teleflex's (TFX) fourth-quarter top line.

2 months ago - Zacks Investment Research

Teleflex (TFX) Q4 Earnings and Revenues Surpass Estimates

Teleflex (TFX) delivered earnings and revenue surprises of 1.98% and 1.87%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

Teleflex Announces Fourth Quarter and Full-Year 2021 Financial Results

WAYNE, Pa., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the fourth quarter ended December 31, 2021.

2 months ago - GlobeNewsWire

Teleflex Receives FDA Clearance for Expanded Indication for Specialty Catheter and Coronary Guidewire Use in CTO PCI ...

Results of CTO-PCI IDE Study Demonstrate Procedural Success with Teleflex Specialty Catheters and Coronary Guidewires in Patients Undergoing Chronic Total Occlusion Percutaneous Coronary Interventions R...

2 months ago - GlobeNewsWire

Teleflex (TFX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Teleflex (TFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 months ago - Zacks Investment Research

Teleflex Announces Fourth Quarter and Full Year 2021 Earnings Conference Call Information

WAYNE, Pa., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its fourth quarter and full year 2021 financial results and provide an operational u...

3 months ago - GlobeNewsWire

Teleflex to Present at the 40th Annual J.P. Morgan Healthcare Conference

WAYNE, Pa., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 40th Annual J.P. Morgan Healthcare Conference on Tu...

4 months ago - GlobeNewsWire

Teleflex (TFX) Banks on Urolift Growth Amid Rising Expenses

Despite reporting softer-than-expected revenues for the third quarter, Teleflex (TFX) notes that customer preference for UroLift continues to be driven by strong clinical results.

5 months ago - Zacks Investment Research